During the past decade, Kobe University Graduate School of Medicine, Department of Cardiology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kobe University Graduate School of Medicine, Department of Cardiology" #1 sponsor was "Kobe University" with 9 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "DePuy Orthopaedics" with 1 trials sponsored, "Emory University" with 1 trials sponsored and "Fresenius Kabi Japan" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kobe University Graduate School of Medicine, Department of Cardiology" #1 collaborator was "HeartFlow, Inc." with 1 trials as a collaborator, "Johnson & Johnson K.K. Medical Company" with 1 trials as a collaborator, "Marquette University" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kobe University Graduate School of Medicine, Department of Cardiology" are "Coronary Artery Disease" (7 trials), "Angina Pectoris" (2 trials), "Coronary Artery Disease Progression" (2 trials), "Coronary Heart Disease" (2 trials) and "Biliary Tract Cancer" (1 trials). Many other conditions were trialed in "Kobe University Graduate School of Medicine, Department of Cardiology" in a lesser frequency.

Most popular intervention types in "Kobe University Graduate School of Medicine, Department of Cardiology" are "Drug" (6 trials), "Device" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alirocumab" (2 trials), "6% hydroxyethyl starch 130/0.4" (1 trials), "6% hydroxyethyl starch 70/0.5 (Salinhes®)" (1 trials), "Alirocumab 75 MG/ML [Praluent]+ Rosuvastatin 10mg/daily" (1 trials) and "Cementless Total Knee Arthroplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kobe University Graduate School of Medicine, Department of Cardiology" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Kobe University Graduate School of Medicine, Department of Cardiology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Kobe University Graduate School of Medicine, Department of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kobe University Graduate School of Medicine, Department of Cardiology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".